Status:
RECRUITING
Carbon Dioxide (CO2) Chemosensitivity and SUDEP
Lead Sponsor:
University of Iowa
Conditions:
Epilepsy
SUDEP
Eligibility:
All Genders
18-99 years
Phase:
NA
Brief Summary
The purpose of this research study is to better understand what causes Sudden Unexpected Death in Epilepsy (SUDEP). This study will enroll subjects from the University of Iowa Hospitals and Clinics (U...
Detailed Description
In this study, the investigators will only enroll adults with confirmed or suspected epilepsy; there is no control group. Patients admitted to the UIHC Epilepsy Monitoring Unit (EMU) for continuous Vi...
Eligibility Criteria
Inclusion
- The subject is between 18 and 99 years of age.
- Confirmed or suspected epilepsy.
- Admission to the EMU for spell characterization (EMU group) or undergoing care in the University of Iowa Health Care Epilepsy Clinic.
Exclusion
- History of uncontrolled cardiac, pulmonary, or hepatic disease.
- Progressive or uncontrolled neurologic disease unrelated to epilepsy.
- Current opioid use.
- Women of child-bearing potential who are pregnant or capable of becoming pregnant (e.g. sexual activity within the past 21 days without a highly effective form of birth control or positive urine pregnancy test).
- Other comorbid condition that may influence the safety or feasibility of HCVR testing.
- Limited decision-making capacity and absence of a qualified representative.
Key Trial Info
Start Date :
December 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2029
Estimated Enrollment :
335 Patients enrolled
Trial Details
Trial ID
NCT04134754
Start Date
December 12 2019
End Date
October 1 2029
Last Update
March 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States, 52242